VOLU SOL INC
NT 10-Q, 2000-02-14
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Previous: PNV INC, 10-Q, 2000-02-14
Next: NORTH ARKANSAS BANCSHARES INC, 10QSB, 2000-02-14



                                  UNITED STATES

                       SECURITIES AND EXCHANGE COMMISSION

                             Washington, D.C. 20549

                                   FORM 12b-25

                           NOTIFICATION OF LATE FILING

(Check one): __  Form 10-KSB __ Form 20-F X Form 10-QSB __ Form N-SAR
                                          --
For period ended: December 31, 1999

            [ ]  Transition Report on Form 10-K and Form 10-KSB
            [ ]  Transition Report on Form 20-F
            [ ]  Transition Report on Form 11-K
            [ ]  Transition Report on Form 10-Q and Form 10-QSB
            [ ]  Transition Report on Form N-SAR
            For the transition period ended

SEC File Number 0-23153

CUSIP Number -

Nothing  in this  form  shall be  construed  to imply  that the  Commission  has
verified any information contained herein.

If the notification  relates to a portion of the filing checked above,  identify
the          item(s)          to         which         the          notification
relates:_________________________________________

                          PART I-REGISTRANT INFORMATION

VOLU-SOL, INC.
- --------------------------------------
Full Name of Registrant

5099 West 2100 South
Salt Lake City, Utah 84120
(801) 974-9474
- --------------------------------------
Address and telephone number of
principal executive office

                       PART II-RULES 12b-25(b) AND (c)

If the subject report could not be filed without  unreasonable effort or expense
and the registrant seeks relief pursuant to Rule 12b-25(b), the following should
be completed. (Check appropriate box)

[X]               (a) The reasons  described in reasonable detail in Part III of
                  this form could not be eliminated without  unreasonable effort
                  or expense;

                                        1
<PAGE>



[X]   (b)         The subject annual report, semi-annual report,
                  transition report on Forms 10-K, 10-KSB, 20-F, 11-K, or
                  Form N-SAR, or portion thereof will be filed on or
                  before the 15th calendar day following the prescribed
                  due date; or the subject quarterly report or transition
                  report on Form 10-Q, 10-QSB, or portion thereof will be
                  filed on or before the fifth calendar day following the
                  prescribed due date; and

[ ]   (c)         The accountant's statement or other exhibit required by
                  Rule 12b-25(c) has been attached if applicable.


                               PART III-NARRATIVE

      State below in  reasonable  detail the reasons why the Form 10-K,  10-KSB,
11-K, 20-F 10-Q, 10-QSB,  N-SAR or the transition report portion thereof,  could
not be filed within the prescribed time period.

      The quarterly  report could not be filed because of delays  encountered in
finalizing the financial and other information needed to complete the report.

                            PART IV-OTHER INFORMATION

(1)   Name and telephone number of person to contact in regard to this
      notification.

W. Wilford Kirton III, CEO       (801)            974-9474
       (Name)                 (Area Code)    (Telephone Number)

(2)   Have all other periodic  reports required under Section 13 or 15(d) or the
      Securities  Exchange Act of 1934 or Section 30 of the  Investment  Company
      Act of 1940 during the  preceding  12 months (or for such  shorter  period
      that the registrant was required to file such  report(s))  been filed?  If
      the answer is no, identify
   report(s).
      X  Yes    __ No

(3) Is it anticipated that any significant  change in results of operations from
the  corresponding  period for the last  fiscal  year will be  reflected  by the
earnings statements to be included in the subject report or portion thereof?

      __ Yes       X  No

            If so:  attach an explanation of the anticipated change, both
            narratively and quantitatively, and, if appropriate, state
         the reasons why a reasonable estimate of the results cannot
       be made.




                                        2
<PAGE>






                            VOLU-SOL, INC.
                 (Name of Registrant as Specified in Charter)

has caused this notification to be signed on its behalf by the
undersigned thereunto duly authorized.



Date   February 14, 2000            By:  /s/ Michael G. Acton
                                    ---------------------------------
                                    Michael G. Acton, Chief Financial
                                    Officer


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission